Antagonist profile of ibodutant at the tachykinin NK2 receptor in guinea pig isolated bronchi.

[1]  P. Santicioli,et al.  Characterization of ibodutant at NK(2) receptor in human colon. , 2013, European journal of pharmacology.

[2]  J. Galzi,et al.  Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration. , 2009, Journal of medicinal chemistry.

[3]  P. Santicioli,et al.  Multifaceted Approach to Determine the Antagonist Molecular Mechanism and Interaction of Ibodutant ([1-(2-Phenyl-1R-{[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl}-ethylcarbamoyl)-cyclopentyl]-amide) at the Human Tachykinin NK2 Receptor , 2009, Journal of Pharmacology and Experimental Therapeutics.

[4]  J. Galzi,et al.  A novel, conformation‐specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Maggi,et al.  MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist. , 2006, European journal of pharmacology.

[6]  C. Maggi,et al.  Pharmacological evaluation of α and β human tachykinin NK2 receptor splice variants expressed in CHO cells , 2004 .

[7]  S. Polikepahad,et al.  Pharmacologic evaluation of neurokinin-2 receptor antagonists in the guinea pig respiratory tract. , 2004, American journal of veterinary research.

[8]  P. Barnes,et al.  Pathophysiology of asthma. , 2003, British journal of clinical pharmacology.

[9]  I. Gibbins,et al.  Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. , 2003, Brain research. Molecular brain research.

[10]  C. Maggi,et al.  Identification of a tachykinin NK(2) receptor splice variant and its expression in human and rat tissues. , 2002, Life sciences.

[11]  J. Galzi,et al.  Mutations in the Extracellular Amino-terminal Domain of the NK2 Neurokinin Receptor Abolish cAMP Signaling but Preserve Intracellular Calcium Responses* , 2002, The Journal of Biological Chemistry.

[12]  P. Dannies.  A serum prolactin-binding protein: implications for growth hormone , 2001, Trends in Endocrinology & Metabolism.

[13]  R. Pauwels,et al.  Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. , 2001, European journal of pharmacology.

[14]  M. Majima,et al.  Nitric oxide is generated in smooth muscle layer by neurokinin A and counteracts constriction in guinea pig airway. , 2001, Nitric oxide : biology and chemistry.

[15]  S. Edelstein,et al.  The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States* , 2001, The Journal of Biological Chemistry.

[16]  H. Meurs,et al.  Role of tachykinin NK2‐receptor activation in the allergen‐induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea‐pigs , 1999, British journal of pharmacology.

[17]  P. Henricks,et al.  Nerve growth factor induces a neurokinin-1 receptor- mediated airway hyperresponsiveness in guinea pigs. , 1999, American journal of respiratory and critical care medicine.

[18]  D. Thompson,et al.  Absence of tachykinin involvement in leukotriene D4 and antigen-induced contraction of guinea pig isolated bronchus. , 1997, The Journal of pharmacology and experimental therapeutics.

[19]  Melanie L. Heavey,et al.  TACHYKININ RECEPTORS MEDIATING NON‐CHOLINERGIC CONTRACTION OF THE GUINEA‐PIG ISOLATED MAIN BRONCHUS IN RESPONSE TO FIELD STIMULATION , 1997, Clinical and experimental pharmacology & physiology.

[20]  A. Kraneveld,et al.  Role for neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs. , 1997, American journal of respiratory and critical care medicine.

[21]  C. Maggi.  The effects of tachykinins on inflammatory and immune cells , 1997, Regulatory Peptides.

[22]  H. Iwagoe,et al.  Evidence that allergen-induced contraction of guinea pig bronchi is mediated in part by the release of tachykinins. , 1997, International archives of allergy and immunology.

[23]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.

[24]  K. Ota.  [Inflammatory mediators in asthma]. , 1996, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[25]  V. Zagorodnyuk,et al.  Neuronal tachykinin NK2 receptors mediate release of non-adrenergic non-cholinergic inhibitory transmitters in the circular muscle of guinea-pig colon , 1995, Neuroscience.

[26]  C. Maggi,et al.  The mammalian tachykinin receptors. , 1995, General pharmacology.

[27]  P. Saldiva,et al.  Neurokinin depletion attenuates pulmonary changes induced by antigen challenge in sensitized guinea pigs. , 1995, The American journal of physiology.

[28]  S. Waserman,et al.  Mast cells and the nerves—potential interactions in the context of chronic disease , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  H. Olpe,et al.  Physiological and pharmacological characterization of the spinal tachykinin NK2 receptor. , 1994, European journal of pharmacology.

[30]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[31]  L. Luo,et al.  Differential effects of selective tachykinin NK2 receptor antagonists in rat spinal cord. , 1994, European journal of pharmacology.

[32]  C. Maggi,et al.  Tachykinin receptors and tachykinin receptor antagonists. , 1993, Journal of autonomic pharmacology.

[33]  C. Maggi,et al.  Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth muscles , 1992, Neuropeptides.

[34]  L. Renzetti,et al.  Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors. , 1992, The Journal of pharmacology and experimental therapeutics.

[35]  J. Morrison,et al.  Evidence for the Co-existence of multiple NK2 tachykinin receptor subtypes in rat bladder , 1992, Neuropeptides.

[36]  C. Maggi,et al.  Heterogeneity of NK-2 tachykinin receptors in hamster and rabbit smooth muscles , 1992, Regulatory Peptides.

[37]  C. Maggi,et al.  On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat , 1991, Neuroscience.

[38]  Y. Lai.  Endogenous tachykinins in antigen-induced acute bronchial responses of guinea pigs. , 1991, Experimental lung research.

[39]  C. Maggi,et al.  Tachykinin receptors and noncholinergic bronchoconstriction in the guinea-pig isolated bronchi. , 1991, The American review of respiratory disease.

[40]  C. Maggi,et al.  Tachykinin receptors in the guinea-pig isolated bronchi. , 1991, European journal of pharmacology.

[41]  E. Ingenito,et al.  Effects of capsaicin on mechanical, cellular, and mediator responses to antigen in sensitized guinea pigs. , 1991, The American review of respiratory disease.

[42]  C. Maggi,et al.  Tachykinins activate guinea‐pig alveolar macrophages: involvement of NK2 and NK1 receptors , 1990, British journal of pharmacology.

[43]  K. Chung,et al.  Inflammatory mediators and asthma. , 1988, Pharmacological reviews.

[44]  E. Naline,et al.  Relative potencies of neurokinins in guinea pig trachea and human bronchus. , 1987, European journal of pharmacology.

[45]  C. Maggi,et al.  Capsaicin desensitization protects from antigen-induced bronchospasm in conscious guinea-pigs. , 1987, European journal of pharmacology.

[46]  J. Nadel,et al.  Neuropeptides degranulate serous cells of ferret tracheal glands. , 1986, The American journal of physiology.

[47]  B. Pernow.  Role of tachykinins in neurogenic inflammation. , 1985, Journal of immunology.

[48]  X. Hua,et al.  Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[49]  A. Saria,et al.  A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[50]  L. Barthó,et al.  Capsaicin-sensitive non-cholinergic excitatory innervation of the guinea-pig tracheobronchial smooth muscle , 1982, Neuroscience Letters.

[51]  T. Hökfelt,et al.  Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man , 2004, Cell and Tissue Research.

[52]  C. Maggi,et al.  The effect of thiorphan and epithelium removal on contractions and tachykinin release produced by activation of capsaicin-sensitive afferents in the guinea-pig isolated bronchus , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[53]  M. Tonini,et al.  Contribution of NK(2) tachykinin receptors to propulsion in the rabbit distal colon. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[54]  D. McDonald,et al.  Proinflammatory Peptides in Sensory Nerves of the Airways , 1998 .

[55]  C. Maggi,et al.  Evidence for tachykinin NK-2B-like receptors in guinea-pig alveolar macrophages. , 1992, Life sciences.

[56]  C. Strader,et al.  Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. , 1992, Molecular pharmacology.

[57]  S. Arii,et al.  Tumoricidal activity of Kupffer cells augmented by anticancer drugs. , 1992, Life sciences.

[58]  I. Honda,et al.  Inhibition of neutral endopeptidase potentiates bronchial contraction induced by immune response in guinea pigs in vitro. , 1991, The American review of respiratory disease.

[59]  P. Barnes.  Neurogenic inflammation in airways and its modulation. , 1990, Archives internationales de pharmacodynamie et de therapie.

[60]  A. Saria,et al.  Polypeptide-containing neurons in airway smooth muscle. , 1987, Annual review of physiology.

[61]  Terrence P. Kenakin,et al.  A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .